<DOC>
	<DOCNO>NCT00904488</DOCNO>
	<brief_summary>The purpose prospective , randomize , open-label study compare two diuretic strategy patient acute decompensated heart failure ( ADHF ) : addition oral thiazide diuretic intravenous bolus ( IVB ) loop diuretic compare transition IVB continuous infusion ( CI ) loop diuretic .</brief_summary>
	<brief_title>Oral Metolazone Intermittent Intravenous Furosemide Versus Continuous Infusion Furosemide Acute Heart Failure</brief_title>
	<detailed_description>Patients hospitalize ADHF secondary fluid overload experience inadequate response IVB furosemide require additional diuresis enrol . Patients randomize one two treatment arm : addition oral metolazone continue IVB furosemide versus transition IVB CI furosemide . A suggested algorithm initial dose titration two diuretic strategy provide . Baseline daily data collection include various efficacy safety endpoint include daily net urine output weight , patient physician global assessment scale , length stay , 30-day death rehospitalization , vital sign , electrolyte , renal function . Clinically meaningful efficacy safety endpoint compare .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<mesh_term>Diuretics</mesh_term>
	<mesh_term>Metolazone</mesh_term>
	<criteria>1 . Greater equal 18 year age 2 . Hospitalized ADHF secondary fluid overload define presence least 1 symptom ( e.g . dyspnea , orthopnea , paroxysmal nocturnal dyspnea ) AND 1 sign ( e.g . rale auscultation , &gt; 2+ peripheral presacral &gt; edema , hepatomegaly , ascites , jugular vein distension &gt; 7 cm , pulmonary vascular congestion chest radiography ) 3 . Inadequate response IV diuretic require additional diuresis determine primary medical team 4 . Received less six dos IV furosemide OR enrol within 72 hour hospital admission 5 . Anticipated need intravenous diuretic therapy least 48 hour 6 . Able provide inform consent 1 . Receiving continuous infusion loop diuretic current hospital visit 2 . Substantial diuretic response prerandomization diuretic dosing high dos diuretic would contraindicate ( base judgement patient 's primary team ) 3 . Planned ongoing intravenous vasoactive therapy ( e.g . inotrope , vasodilator ) mechanical support ( e.g . intraaortic balloon pump , ventricular assist device ) ADHF hospitalization 4 . Planned elective admission elective placement/revision cardiovascular device ( e.g . defibrillator , biventricular pacemaker ) hospitalization within precede 7 day 5 . Systolic blood pressure &lt; 90 mmHg 6 . Serum creatinine &gt; 3 mg/dL baseline renal replacement therapy include ultrafiltration 7 . Serum potassium &lt; 3.5 mEq/L ( 3.0 3.4 mEq/L allow supplemental potassium administer ) 8 . Serum magnesium &lt; 1.6 mg/dL ( 1.4 1.5 mg/dL allow supplemental magnesium administer ) 9 . Acute coronary syndrome hemodynamically significant arrhythmia cause worsen HF 10 . Severe , uncorrected primary cardiac valvular disease , acute myocarditis , constrictive pericarditis , hypertrophic obstructive cardiomyopathy , restrictive constrictive cardiomyopathy , complex congenital heart disease 11 . Primary pulmonary hypertension right side heart failure 12 . Use iodinate radiocontrast material prior 72 hour plan within next 48 hour 13 . Enrollment plan enrollment another randomize clinical trial hospitalization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Acute Decompensated Heart Failure</keyword>
	<keyword>Diuretics</keyword>
</DOC>